Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial

N. Colombo, D. S. McMeekin, P. E. Schwartz, C. Sessa, P. A. Gehrig, R. Holloway, P. Braly, D. Matei, A. Morosky, P. F. Dodion, M. H. Einstein, F. Haluska

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences